Amount Raised
$10.1 Million
Round Type
Series C
St. LouisHealthcareDescription
Immunophotonics has closed $10 million in Series C financing to support the ongoing clinical development of its lead drug candidate, IP-001. This funding will enable advancement of clinical Phase 2 programs and key corporate objectives. The company appointed Robert H. Arch, Ph.D., as President and CEO, effective September 1, 2026
Quick answer
Immunophotonics raised $10.1 Million in a Series C round, dated September 1, 2026. Immunophotonics is based in St. Louis, Missouri, United States.
- How much did Immunophotonics raise?
- Immunophotonics raised $10.1 Million in a Series C round on September 1, 2026.
- What does Immunophotonics do?
- Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity.
- Where is Immunophotonics based and how big is it?
- Immunophotonics is based in St. Louis, Missouri, United States. Fundz records about 18 employees.
- Who are the decision-makers at Immunophotonics?
- Fundz holds 1 contact at Immunophotonics, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Immunophotonics that raised within 45 days of this round, from Fundz verified event records.
- Excision Medical raised $7.3M on October 16, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Sirona Medical, Inc. raised $40M (Series D) on October 15, 2026.
- Ospitek raised an undisclosed amount on October 13, 2026.
- Sensydia Corp raised $8.9M (Seed) on October 13, 2026.
Who to call at Immunophotonics, and when
A new round usually means Immunophotonics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Immunophotonics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Immunophotonics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Immunophotonics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Immunophotonics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Immunophotonics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.